Investment Research & Advisory Group, Inc. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Investment Research & Advisory Group, Inc. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$49,000
+88.5%
1,134
+89.0%
0.04%
+118.8%
Q1 2022$26,0000.0%6000.0%0.02%0.0%
Q4 2021$26,000
+13.0%
6000.0%0.02%
+6.7%
Q3 2021$23,000
-4.2%
6000.0%0.02%
-6.2%
Q2 2021$24,000
+14.3%
6000.0%0.02%
+6.7%
Q1 2021$21,000
-4.5%
6000.0%0.02%
-6.2%
Q4 2020$22,000
-33.3%
600
-30.6%
0.02%
-40.7%
Q3 2020$33,000
-5.7%
8640.0%0.03%
-12.9%
Q2 2020$35,000
+6.1%
8640.0%0.03%0.0%
Q1 2020$33,000
+175.0%
864
+227.3%
0.03%
+181.8%
Q4 2019$12,0002640.01%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2020
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders